Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.96 |
| ▸ | ACHE | P22303 | 13/20 | 0.59 |
| ▸ | NAAA | Q02083 | 1/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.52 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.52 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11653539 | 0.98 | EPHX1 (1.00) | EPHX1ACHENAAA | |
| SCHEMBL12635224 | 0.98 | EPHX1 (1.00) | EPHX1ACHENAAA | |
| SCHEMBL4616449 | 0.98 | EPHX1 (1.00) | EPHX1ACHENAAA | |
| SCHEMBL11319803 | 0.98 | EPHX1 (1.00) | EPHX1ACHENAAA | |
| SCHEMBL1894163 | 0.98 | EPHX1 (1.00) | EPHX1ACHENAAA | |
| SCHEMBL12195976 | 0.98 | EPHX1 (1.00) | EPHX1ACHENAAA | |
| SCHEMBL10816925 | 0.98 | EPHX1 (1.00) | EPHX1ACHENAAA | |
| SCHEMBL968307 | 0.93 | — | — | |
| Acetic Acid SCHEMBL4300713 | 0.92 | EPHX1 (0.89) | EPHX1ACHENAAA | |
| SCHEMBL19879549 | 0.92 | EPHX1 (0.89) | EPHX1ACHENAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0087000-B1 | N-OXALYL DERIVATIVES OF N-METHYL CARBAMATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES | BAYER AG (DE) | 1985-11-13 | — | — | EP | claimed |
| US-4014923-A | INSECTICIDES AND ACARICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-03-29 | — | — | US | claimed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| US-20230130155-A1 | MRNAS ENCODING METABOLIC REPROGRAMMING POLYPEPTIDES AND USES THEREOF | ARES CAPITAL CORPORATION, AS AGENT | 2023-04-27 | — | — | US | disclosed |
| EP-3852746-A1 | CYCLOPENTYL ACIDS AS LPA ANTAGONISTS | Bristol-Myers Squibb Company (US) | 2021-07-28 | — | — | EP | disclosed |
| US-20210040062-A1 | AZOLE-SUBSTITUTED PYRIDINE COMPOUND | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2021-02-11 | — | — | US | disclosed |
| EP-3728240-A1 | ISOXAZOLE O-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS | Bristol-Myers Squibb Company (US) | 2020-10-28 | — | — | EP | disclosed |
| WO-2020205867-A1 | COMPOUNDS TARGETING PRMT5 | ALIGOS THERAPEUTICS, INC. (US) | 2020-10-08 | — | — | WO | disclosed |
| WO-2020060915-A1 | CYCLOPENTYL ACIDS AS LPA ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2020-03-26 | — | — | WO | disclosed |
| EP-0033098-A2 | N-methyl-N-silyl-carbamates, processes for their preparation and their use as pesticides | BASF Aktiengesellschaft (DE) | 1981-08-05 | — | — | EP | disclosed |
| US-4211790-A | Combating arthropods with an oxime ester of N-carboxylated-carbamate | BAYER AKTIENGESELLSCHAFT (DE) | 1980-07-08 | — | — | US | disclosed |
| EP-0008651-A1 | Derivatives of triazole, process for their production and insecticides containing them | BASF Aktiengesellschaft (DE) | 1980-03-19 | — | — | EP | disclosed |
| EP-0007589-A1 | Insecticide agents comprising carbamate as active ingredient and triazole derivatives as synergists | BASF Aktiengesellschaft (DE) | 1980-02-06 | — | — | EP | disclosed |
| US-4109011-A | INSECTICIDE CARBAMATES OF N-(POLYCHLOROALLYL)-AMINO-PHENOLS | MONTEDISON S.P.A. (IT) | 1978-08-22 | — | — | US | disclosed |
| US-4014923-A | INSECTICIDES AND ACARICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-03-29 | — | — | US | disclosed |
| US-4014923-A | INSECTICIDES AND ACARICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-03-29 | — | — | US | disclosed |
| US-4014923-A | INSECTICIDES AND ACARICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-03-29 | — | — | US | disclosed |
| US-3857860-A | N-CARBOXYLATED N-METHYLCARBAMIC ACID ARYL ESTERS | BAYER AG | 1974-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210040062-A1 | AZOLE-SUBSTITUTED PYRIDINE COMPOUND | CYP2F1, CYP21A2, CYP11B1 | EPHX1 144/4885ACHE 2138/4885NAAA 807/4885 |
| US-20230130155-A1 | MRNAS ENCODING METABOLIC REPROGRAMMING POLYPEPTIDES AND USES THEREOF | HMOX1, CD209, HMOX2 | EPHX1 566/4885ACHE 4307/4885NAAA 1955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.